Publications

MDC1 Directly Binds Phosphorylated Histone H2AX to Regulate Cellular Responses to DNA Double-Strand Breaks (DOI:10.1016/j.cell.2005.09.038)

Authors: M Stucki, JA Clapperton, D Mohammad, MB Yaffe, SJ Smerdon, SP Jackson

E-pub date: 24 Mar 2006

Journal name: Cell

Structure of an Xrcc4-DNA ligase IV yeast ortholog complex reveals a novel BRCT interaction mode.

Authors: AS Doré, N Furnham, OR Davies, BL Sibanda, DY Chirgadze, SP Jackson, L Pel...

E-pub date: 7 Mar 2006

Journal name: DNA Repair (Amst)

High-grade glioma: can we teach an old dogma new tricks?

Authors: RJ Gilbertson

E-pub date: 1 Mar 2006

Journal name: Cancer Cell

Mutational analysis of PDGFR-RAS/MAPK pathway activation in childhood medulloblastoma.

Authors: RJ Gilbertson, JA Langdon, A Hollander, R Hernan, TL Hogg, A Gajjar, C Full...

E-pub date: 1 Mar 2006

Journal name: Eur J Cancer

Rat tumor response to the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid as measured by dynamic contrast-enhanced magnetic resonance imaging, plasma 5-hydroxyindoleacetic acid levels, and tumor necrosis.

Authors: LD McPhail, DJO McIntyre, C Ludwig, P Kestell, JR Griffiths, LR Kelland, SP...

E-pub date: 1 Mar 2006

Journal name: Neoplasia

Erratum: Probing tumor phenotypes using stable and regulated synthetic microRNA precursors (Nature Genetics (2005) 37 (1289-1295))

Authors: RA Dickins, MT Hemann, JT Zilfou, DR Simpson, I Ibarra, GJ Hannon, SW Lowe

E-pub date: 1 Mar 2006

Journal name: Nature Genetics

Bex2 identifies a novel subtype of breast cancer associated with estrogen-response and NGF/NF-KB pathway

Authors: A Naderi, A Teschendorff, J Beigel, M Cariati, I Ellis, J Brenton, C Caldas

E-pub date: 1 Mar 2006

Journal name: European Journal of Cancer Supplements

Robust identification of novel prognostic gene-signatures in breast cancer

Authors: A Naderi, AE Teschendorff, NL Barbosa-Morais, JFR Robertson, IO Ellis, JD B...

E-pub date: 1 Mar 2006

Journal name: European Journal of Cancer Supplements

Filters

Research Groups

Core Facilities

Start date

End date

MDC1 Directly Binds Phosphorylated Histone H2AX to Regulate Cellular Responses to DNA Double-Strand Breaks (DOI:10.1016/j.cell.2005.09.038)

Structure of an Xrcc4-DNA ligase IV yeast ortholog complex reveals a novel BRCT interaction mode.

High-grade glioma: can we teach an old dogma new tricks?

Mutational analysis of PDGFR-RAS/MAPK pathway activation in childhood medulloblastoma.

Rat tumor response to the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid as measured by dynamic contrast-enhanced magnetic resonance imaging, plasma 5-hydroxyindoleacetic acid levels, and tumor necrosis.

Erratum: Probing tumor phenotypes using stable and regulated synthetic microRNA precursors (Nature Genetics (2005) 37 (1289-1295))

Bex2 identifies a novel subtype of breast cancer associated with estrogen-response and NGF/NF-KB pathway

Robust identification of novel prognostic gene-signatures in breast cancer

Themes

Filters

Research Groups

Core Facilities

Start date

End date

MDC1 Directly Binds Phosphorylated Histone H2AX to Regulate Cellular Responses to DNA Double-Strand Breaks (DOI:10.1016/j.cell.2005.09.038)

Structure of an Xrcc4-DNA ligase IV yeast ortholog complex reveals a novel BRCT interaction mode.

High-grade glioma: can we teach an old dogma new tricks?

Mutational analysis of PDGFR-RAS/MAPK pathway activation in childhood medulloblastoma.

Rat tumor response to the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid as measured by dynamic contrast-enhanced magnetic resonance imaging, plasma 5-hydroxyindoleacetic acid levels, and tumor necrosis.

Erratum: Probing tumor phenotypes using stable and regulated synthetic microRNA precursors (Nature Genetics (2005) 37 (1289-1295))

Bex2 identifies a novel subtype of breast cancer associated with estrogen-response and NGF/NF-KB pathway

Robust identification of novel prognostic gene-signatures in breast cancer